D. Spaëth

Efficacy and Safety of Two Neoadjuvant Strategies With Bevacizumab in MRI-Defined Locally Advanced T3 Resectable Rectal Cancer: Final Results of a Randomized, Noncomparative Phase 2 INOVA Study.

L. Quéro, T. Conroy, C. Borg, 2019, Clinical colorectal cancer.

Epoetin beta once weekly: review of its efficacy and safety in patients with chemotherapy-induced anemia

D. Spaëth, 2008, Expert review of anticancer therapy.

Treatment patterns, clinical outcomes and health care costs associated with her2-positive breast cancer with central nervous system metastases: a French multicentre observational study

I. Durand-zaleski, P. Cottu, M. Gutiérrez, 2013, BMC Health Services Research.

Brain metastases from epithelial ovarian carcinoma.

T. Conroy, D. Spaëth, B. Weber, 2000, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Epoetin β Once-Weekly Therapy in Anemic Patients with Solid Tumors and Non-Myeloid Hematological Malignancies Receiving Chemotherapy

S. Oudard, N. Ifrah, K. Ghomari, 2008, Oncology.

Real-World Safety and Efficacy Outcomes with Abiraterone Acetate Plus Prednisone or Prednisolone as the First- or Second-Line Treatment for Metastatic Castration-Resistant Prostate Cancer: Data from the Prostate Cancer Registry

N. Lumen, G. Kramer, A. Bjartell, 2021, Targeted Oncology.

Real-World Outcomes in First-Line Treatment of Metastatic Castration-Resistant Prostate Cancer: The Prostate Cancer Registry

N. Lumen, G. Kramer, A. Bjartell, 2020, Targeted Oncology.

Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromatase inhibitors: a GINECO study.

I. Ray-Coquard, T. Bachelot, C. Bourgier, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Severe hypertriglyceridaemia during treatment with capecitabine

N. Gambier, P. Gillet, J. Scala-Bertola, 2011, British Journal of Cancer.

Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromatase inhibitors: a GINECO study.

I. Ray-Coquard, T. Bachelot, C. Bourgier, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.